BRIACELL THERAPEUTICS CORP. Proceeds from Issuance of Warrants
BRIACELL THERAPEUTICS CORP. (BCTX) reported Proceeds from Issuance of Warrants of $50.90 million for the 3-month period ending 2025-10-31, per its 10-Q filed 2025-12-11.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfWarrants · last filed 2025-12-11
- BRIACELL THERAPEUTICS CORP. proceeds from issuance of warrants for the quarter ending 2025-10-31 was $50.90M.
- BRIACELL THERAPEUTICS CORP. proceeds from issuance of warrants for fiscal 2025 was $50.90M.
- BRIACELL THERAPEUTICS CORP. proceeds from issuance of warrants for fiscal 2021 was $1.82M.
| Period end | Proceeds from Issuance of Warrants 3 month | Proceeds from Issuance of Warrants 12 month |
|---|---|---|
| 2025-10-31 | $50.90M 10-Q · filed 2025-12-11 | |
| 2025-07-31 | $50.90M 10-K · filed 2025-10-16 | |
| 2021-07-31 | $1.82M 10-K · filed 2022-10-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |